This week, Roche unveils their new AI algorithm for predicting diabetic retinopathy progression, the NEI and Prova Education develops curriculum to educate physicians about diabetic eye diseases and a theatre actor with Stargardt disease makes his TV debut. Source: AAO
This secondary analysis of data from 2 clinical trials explores whether the type of anti-VEGF agent and baseline characteristics influence fellow eye conversion to neovascular AMD. Source: AAO
This NEI-funded trial compared 2 commonly used, steroid-sparing, immunosuppressive drugs as a first-line treatment for noninfectious uveitis. Source: AAO
Investigators evaluated the outcomes of transepithelial phototherapeutic keratectomy with corneal collagen crosslinking in patients with pellucid marginal degeneration. Source: AAO
This study assessed the clinical efficacy and safety of primary selective laser trabeculoplasty (SLT) for open-angle glaucoma (OAG) and ocular hypertension. Source: AAO
This report details the current approach for the management of syphilitic uveitis. Source: AAO
This week, a baby beams at his father after surgery for congenital cataracts, an ultraprecise cannula delivers drugs into retinal veins and the FDA clears Canon’s automated OCT device. Source: AAO
Investigators assessed the incidence of ocular myasthenia gravis (MG) and identified risk factors for transformation to generalized MG. Source: AAO
A novel monotherapy may reduce the risk of relapse for patients with neuromyelitis optica spectrum disorder (NMOSD), according to data presented by Genentech at the 35th Congress of the European Committee for Treatment and Research in Multiple Sclerosis. Source: AAO
This prospective study examined the prevalence, incidence and natural history of subclinical macular neovascularization in eyes with unilateral dry AMD. Source: AAO